|
|
 |
HIV Prevention in Treatment Settings: U.S. and International Priorities: DHHS
|
The estimated annual number of new HIV infections in the United States has remained steady at 40,000 for nearly 10 years and HIV rates in many countries continue to rise alarmingly.
Domestic and international HIV prevention programs have generally focused on HIV-negative persons, to help them avoid becoming infected. However, it has become increasingly apparent that to stem the tide of new infections, additional attention and resources should be focused on persons living with HIV, especially those in treatment. Behavioral interventions in HIV/AIDS treatment settings represent a critical domestic priority and are an emergent international priority.
To develop enhanced HIV prevention strategies in treatment settings, there are important research gaps in basic, behavioral science, medical, and policy areas that need to be addressed. Studies are needed to better understand the associations among HIV treatment response, treatment adherence, risk behavior, and other psychosocial factors that are likely to impact these variables (e.g., housing instability, substance abuse, depression, and domestic violence); develop innovative approaches to risk behavior change based in treatment settings, especially interventions that combine behavioral and medical/biological components; examine optimal mechanisms for referral to services for prevention needs that are not feasible in medical settings; increase medical care providers' linkage of persons to care who had previously not known their HIV serostatus; and improve utilization of systems to facilitate partner notification.
This request for applications (RFA) briefly reviews the complex interaction of basic, behavioral science, medical, and public policy issues that present challenges for the integration of HIV prevention into clinical care settings, and outlines important research priorities.
Sponsor: Department of Health and Human Services (DHHS) and National Institutes of Health (NIH)
Ref No: 72876
Deadline: October 29, 2002. Although not required, prospective applicants are asked to submit a letter of intent by September 27, 2002.
Eligibility: Small Business
Academic Institution or Government or Nonprofit
Ph.D./M.D./Other Professional
Contact details: Christopher M. Gordon, Ph.D.
Address: National Institute of Mental Health
Division of Mental Disorders, Behavioral Research, and AIDS
6001 Executive Boulevard, Room 6204, MSC 9619, Bethesda, Maryland, 20892-9619, USA
Phone: +1 (301) 443-1613, Fax: +1 (301) 443-9719, email: [email protected] |
| Was this article helpful to you? |
 ?50%???? ?50%
|
|
Back
|
|
|
|
